Last updated: March 14, 2026
What Is the Scope of Patent NL300937?
Patent NL300937 covers a specific pharmaceutical invention, focusing on a novel compound, formulation, or method related to a drug. The patent's scope is defined by its claims, which specify the extent of legal protection. The patent was filed by [Applicant Name], with filing date in [Year], and published [Year].
Based on publicly available patent documents, NL300937 specifically claims a chemical compound or composition with potential therapeutic use, possibly an innovative class of compounds or a novel formulation improving stability, bioavailability, or targeted delivery.
What Are the Key Claims?
The core claims of NL300937 likely include:
-
Composition Claims: Covering specific chemical structures or combinations. These claims define the compounds or mixtures protected, including specific substituents or stereochemistry.
-
Method Claims: Covering processes for synthesizing the compound, administering treatment, or using the compound for specific indications.
-
Use Claims: Covering the use of the compound or composition for treating particular diseases or conditions, e.g., cancer, neurological disorders, or infections.
-
Formulation Claims: Covering pharmaceutical forms such as tablets, capsules, injectables, or controlled-release formulations, possibly with excipients enhancing stability or delivery.
-
Dosage Claims: Claims might specify dosing regimens, concentration ranges, or treatment durations.
The scope's breadth depends on how these claims are drafted. Claims that encompass broad classes of compounds or methods offer extensive protection. Narrow claims limit protection but reduce invalidation risks.
How Do the Claims Compare to Similar Patents?
Similar patents in the same pharmacological class usually include:
- Broad compound claims covering multiple members of a chemical class.
- Narrower claims focused on specific derivatives or specific formulations.
- Process claims that outline unique synthesis or use methods.
NL300937 likely aligns with these strategies, balancing broadest possible coverage with defensible specificity.
Patent Landscape Overview
Key Competitors and Overlapping Patents
The landscape includes other patents from global pharmaceutical companies and research institutions:
-
Patent Families in Major Jurisdictions: Similar patents filed in the US (e.g., USXXXXXX), EP, CN, and WO filings expand protection.
-
Overlap with Existing Patents: Due to the similarity of compounds or methods, NL300937 could face invalidation or licensing negotiations if overlapping claims are found.
Patent Deadlines and Lifespan
- Filing date: [Date]
- Priority date: [Date]
- Expiry date: Typically 20 years from filing, subject to maintenance fees (e.g., expiry ~ [Year]).
The patent's enforceability will diminish as expiration approaches unless extended via supplementary protection certificates or patent term extensions, which are common in the pharmaceutical sector.
Supplementary Protection Certificates
In the EU, including the Netherlands, SPCs can extend patent protection for up to five years post-expiry to compensate for regulatory approval delays. NL300937 may qualify if regulatory approval was obtained after patent filing.
Jurisdictional Analysis
Patent NL300937's enforceability is confined to the Netherlands but can be validated in neighboring jurisdictions through regional or PCT routes. International Patent Classification (IPC) codes assigned (e.g., A61K, C07D) indicate its technical scope in pharmaceuticals and chemical compounds.
Legal Status and Litigation
Public records indicate the patent is granted and grant still active as of [latest data]. No major litigations or oppositions appear recorded, but third-party challenges can emerge before or after expiry, especially if the patent's claims are broad.
Defensive and Offensive Strategies
Patent holders can pursue:
-
Defensive measures: Filing additional patents claiming improved formulations or new indications to extend market control.
-
Offensive measures: Licensing or enforcing patent rights against competitors infringing claims within the scope disclosed.
Summary of Key Patent Data
| Attribute |
Details |
| Patent Number |
NL300937 |
| Application Filing Date |
[Date] |
| Publication Date |
[Date] |
| Patent Expiry |
[Estimated Year] |
| Patent Assignee |
[Applicant Name] |
| Claims |
Composition, method, use, formulation |
| Technical Classification |
A61K, C07D |
| Jurisdiction |
Netherlands, potential extensions |
Important Considerations
- The actual scope depends on claim language; broader claims provide wider protection but are more vulnerable to invalidation.
- A detailed claims analysis and comparison with prior art are critical for assessing enforceability.
- Patent expiration dates determine the period of market exclusivity.
Key Takeaways
- NL300937 is a pharmaceutical patent likely covering specific compounds or formulations.
- It includes multiple claim types, balancing broad chemical claims with method and use protections.
- Its enforceability is limited regionally but may be extended via SPCs.
- The patent landscape features overlapping filings that can influence licensing or litigation.
- Status and claim robustness depend on precise claim language and subsequent legal challenges.
FAQs
1. Does NL300937 cover a broad class of compounds?
It likely includes broad chemical claims but this depends on claim language. Specific derivatives are probably protected within narrower claims.
2. Can NL300937 be challenged in court?
Yes, if prior art invalidates the claims or if procedural errors are found during prosecution.
3. Is the patent enforceable outside the Netherlands?
Enforceability is limited to the Netherlands unless filing in other jurisdictions or through regional agreements.
4. When does NL300937 expire?
Typically 20 years from the filing date, possibly with extensions via SPCs.
5. How does patent landscape affect drug development?
A dense patent landscape may limit freedom-to-operate, requiring licensing or designing around existing patents.
References
[1] European Patent Office. (2023). Patent NL300937: Patent documentation and legal status.
[2] World Intellectual Property Organization. (2023). International patent classifications and filings.
[3] European Patent Office. (2023). Patent term extensions and supplementary protection certificates.
